They arrive in the new field of medicine. During the XLVIII National Congress of the "Italian Society of Rheumatology, held in Rimini, has been much talk of two serious diseases: rheumatoid arthritis and scleroderma.
During the meeting, researchers discussed the possibility of fielding a "pre-tests" could therefore predict that today these diseases appear to be quite disabling.
But what is rheumatoid arthritis? It 'a chronic disease that lasts. Arthritis affects the "synovial membrane" that ignites.
Over time you get to the gradual erosion and bone destruction. According to recent data from rheumatoid arthritis primarily affects women, particularly in the age group ranging from 35 to 50 years.
These words Nazzarena Malavolta, head of the Center for Rheumatology AO University St. Orsola-Malpighi in Bologna: "Many rheumatic diseases have an autoimmune basis of developing a genetic component in determining the susceptibility 'to the development of disease."
Dr. Malavolta explains that "The two Italian studies identify biomarkers that could provide some useful answers to the severity of the disease and the type of patient response to treatment with new drugs, including biotechnology."
No comments:
Post a Comment